
Navin Hospicare Private Limited
About Navin Hospicare Private Limited
Data last updated:
Navin Hospicare Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 May 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U52100UP2022PTC164978.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajeev Ahuja and Pradeep Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at NH – 03 Alpha – 2 Greater Noida, Uttar Pradesh, India – 201308.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.98 Cr. For the same year it recorded a net profit of ₹32.07 Lakh (net margin 10.8%) and EBITDA of ₹43.2 Lakh (EBITDA margin 14.5%).
Company details
Contact details
Navin Hospicare Private Limited's registered office is in Noida, Uttar Pradesh.
- Registered AddressNH – 03 Alpha – 2 Greater Noida, Uttar Pradesh, India – 201308
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Navin Hospicare Private Limited
FY 2025 filings availableNavin Hospicare Private Limited reported revenue of ₹2.98 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹43.2 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹32.07 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 14.5% | ||
| Net Profit Margin | 10.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Navin Hospicare Private Limited, buy the company report.
Board of directors of Navin Hospicare Private Limited
Navin Hospicare has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Ahuja | Director | 27 May 2022 | 4 Years 5 Months | Current |
| Pradeep Tyagi Also directs: Green City Pharmacist LLP, Navin Medicare Private Limited, Aar Aar Medical Services Private Limited and 1 more | Director | 27 May 2022 | 4 Years 5 Months | Current |
| Deepshikha Also directs: Navin Medicare Private Limited | Director | 27 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Navin Hospicare Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sonos Healthcare India Private Limited | ₹2.99 Cr (FY 2024) | -30.0% | Coimbatore, Tamil Nadu, India | |||
| Sumerax Life Science Private Limited | ₹2.99 Cr (FY 2024) | 41.0% | Delhi, India | |||
| Rosecure Pharma Private Limited | ₹2.99 Cr (FY 2025) | -38.0% | New Patel Nagar, Uttar Pradesh, India | |||
| Bio Organic Life Sciences Private Limited | ₹2.99 Cr (FY 2024) | 4.0% | Patna, Bihar, India | |||
| Delta Plus Lubricants and Chemicals Private Limited | ₹2.99 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Navin Hospicare Private Limitedthis company | ₹2.98 Cr (FY 2025) | ₹32.07 Lakh | 10.8% | Noida, Uttar Pradesh, India | ||
| Savom Remedies P.Ltd. | ₹2.98 Cr (FY 2025) | -6.0% | Mumbai-4000102, Maharashtra, India | |||
| Cortina Laboratories Private Limited | ₹2.98 Cr (FY 2025) | -5.0% | Lucknow, Uttar Pradesh, India | |||
| Azruthi Wellness Private Limited | ₹2.98 Cr (FY 2025) | 32.0% | Bangalore, Karnataka, India | |||
| Reliabo Pharma India Private Limited | ₹2.98 Cr (FY 2024) | -56.0% | Guwahati, Assam, India | |||
| Jona Techsystems Private Limited | ₹2.98 Cr (FY 2025) | 17990.0% | New Delhi, Delhi, India |
To see the full peer comparison of Navin Hospicare Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Navin Hospicare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Navin Hospicare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Navin Hospicare Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Navin Hospicare Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Deepshikha was appointed as Director on 27 May 2022.
Frequently asked questions
Navin Hospicare is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 May 2022 (4+ years old) and is registered under CIN U52100UP2022PTC164978.
Navin Hospicare has 3 current directors:
- Rajeev Ahuja - Director
- Pradeep Tyagi - Director
- Deepshikha - Director
The latest financial statements of Navin Hospicare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Navin Hospicare is U52100UP2022PTC164978. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Navin Hospicare was incorporated on 27 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Navin Hospicare by revenue are Sonos Healthcare India Private Limited, Sumerax Life Science Private Limited, Rosecure Pharma Private Limited, Bio Organic Life Sciences Private Limited, Delta Plus Lubricants and Chemicals Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution).
Deepshikha was appointed as Director on 27 May 2022. Pradeep Tyagi was appointed as Director on 27 May 2022. Rajeev Ahuja was appointed as Director on 27 May 2022.
The registered office of Navin Hospicare is at NH – 03 Alpha – 2 Greater Noida, Uttar Pradesh, India – 201308.
Navin Hospicare operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Navin Hospicare can be reached at its registered office: NH – 03 Alpha – 2 Greater Noida, Uttar Pradesh, India – 201308.
Navin Hospicare is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.

